Landmark FDA Action Requires New Warnings About NAION, a Serious Eye Condition That Can Cause Sudden and Permanent Vision Loss

PORT WASHINGTON, N.Y., Nov. 10, 2026 /PRNewswire/ -- Parker Waichman LLP, a national law firm representing individuals who have suffered serious injuries associated with prescription medications, today welcomed the U.S. Food and Drug Administration's decision requiring manufacturers of GLP-1 medications to add warnings concerning the potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a serious eye condition that can cause sudden and permanent vision loss.